Nexmr
Zurich, CH · 2 known investors
Find your way into Nexmr
NexMR, an ETH Zurich spin-off, develops light-coupled NMR hardware, consumables, and automated analysis software to increase throughput and reduce resource use in NMR-based drug discovery pipelines. Its sensitivity-enhanced technology targets early-stage drug discovery workflows, including hit affinity determination and screening of challenging targets.
Founders & leadership
FT
Félix TorresinCo-founder & CEOA pharmacist by training, Félix Torres is co-founder and CEO of NexMR, which develops NMR hardware, consumables, and analysis software to accelerate pharmaceutical R&D. He also serves as director of business development at Magritek, where he works with benchtop NMR users to align deployment strategies with their operational needs.
MB
Matthias BütikoferinCo-founder & CSO
Board
RR
Roland RiekScientific Advisor
AS
Anil SethiBoard Member
Investors · 2
Frequently asked questions
- What does Nexmr do?
- NexMR, an ETH Zurich spin-off, develops light-coupled NMR hardware, consumables, and automated analysis software to increase throughput and reduce resource use in NMR-based drug discovery pipelines. Its sensitivity-enhanced technology targets early-stage drug discovery workflows, including hit affinity determination and screening of challenging targets.
- Who founded Nexmr?
- Nexmr was founded by Félix Torres, Matthias Bütikofer.
- Who are Nexmr's investors?
- Nexmr's investors include Kickfund, QAI Ventures.
- Where is Nexmr headquartered?
- Nexmr is headquartered in Zurich, CH.